×

or


IBC Barred by Limitation or Not?

Varsha Banerjee | November 2018

The aspect of applicability of the Limitation Act, 1963 (Limitation Act) to the proceedings under the Insolvency and Bankruptcy Code, […]

Read More

Enforceability of Interim Order Passed by the Arbitral Tribunal

Niraj Singh | November 2018

Earlier statute does not confer power on the Arbitral Tribunal to enforce interim order passed under Section 17 of the […]

Read More

A Precarious Balance: The Fine Line between Freedom of Speech & Expression & the Right to Reputation

Ashima Obhan | November 2018

Defamation is an allencompassing term that covers any communication, written or spoken, that harms a person’s reputation; decreases the respectregard, […]

Read More

Corporate Insolvency Resolution Process Cost under the Insolvency and Bankruptcy Code 2016

Sourav Ghosh | November 2018

Section 5(13) of the Insolvency and Bankruptcy Code 2016 (hereinafter referred to as the ‘Code’) defines the insolvency resolution process […]

Read More

Companies Amendment Ordinance, 2018: A Primer

Manoj Kumar | November 2018

The Companies Amendment Ordinance, 2018 (“Ordinance”) promulgated effective from 2nd November, 2018, made amendments to the provisions of Companies Act, […]

Read More

Blockchain Technology and the Real Estate Sector

Hardeep Sachdeva | November 2018

New technologies have disrupted various industries across the world. Blockchain is one such technology, which may have the potential to […]

Read More

Conceptual Similarity of Trade Marks: The Indian Position

Sangeeta Goel | November 2018

It is a well settled and well recognized principle of trade mark law that rival marks are to be compared […]

Read More

Fugitive Economic Offenders Act (FEOA) – An Act to Tighten the Noose on Indian Billionaires!

Neeti Gharat | November 2018

The Parliament recently enacted a crucial piece of legislation called the Fugitive Economic Offenders Act, 2018 to provide measures to […]

Read More

Lack of Legal & Regulatory Framework for Biosimilars: Hindrance for Dispute Resolution in India

Garima Sahney | October 2018

“A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an […]

Read More

Failure to Determine the Seat of Arbitration

S. Ravi Shankar | October 2018

In a recent Judgment dated 25th September 2018, Supreme Court of India, in the matter of Union of India Vs […]

Read More